Effect of estrogen and AT1 receptor blocker on neointima formation

Hypertension

Volumn 40, Issue 4, 2002, Pages 451-457

  Liu, Hong Wei ^a   Iwai, Masaru ^a   Takeda Matsubara, Yuko ^a   Wu, Lan ^a   Li, Jian Mei ^a   Okumura, Midori ^a   Cui, Tai Xing ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; Estrogen; Kinase; STAT; Vascular remodeling

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BROXURIDINE; ESTRADIOL; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE; OLMESARTAN; STAT PROTEIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; CARDIOTONIC AGENT; DNA; DNA BINDING PROTEIN; IMIDAZOLE DERIVATIVE; STAT1 PROTEIN; STAT1 PROTEIN, MOUSE; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE; TETRAZOLE DERIVATIVE; TRANSACTIVATOR PROTEIN;

ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; ENZYME PHOSPHORYLATION; FEMALE; INTIMA; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIVISION; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOSPHORYLATION; SEX DIFFERENCE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIAL OCCLUSIVE DISEASES; CARDIOTONIC AGENTS; CELL DIVISION; DNA; DNA-BINDING PROTEINS; ESTRADIOL; FEMALE; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; SEX FACTORS; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TETRAZOLES; TRANS-ACTIVATORS;

EID: 0036790596     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000033466.05496.89     Document Type: Article

References (25)

1. Kuroski de Bold ML. Estrogen, natriuretic peptides and the renin-angiotensin system. Cardiovasc Res. 1999;41:524-531.
2. Klett C, Ganten D, Hellmann W, Kaling M, Ryffel GU, Weimar-Ehl T, Hackenthal E. Regulation of angiotensinogen synthesis and secretion by steroid hormones. Endocrinology. 1992;130:3660-3668.
3. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Reigger GA. Effects of estrogen replacement therapy on renin-angiotensin system in postmenopausal women. Circulation. 1997;95:39-45.
4. Sanada M, Higashi Y, Nakagawa K, Sasaki S, Kodama I, Sakashita T, Tsuda M, Ohama K. Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity. Atherosclerosis. 2001;158:391-397.
5. Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, Stablein A, Beckers F, Smits JFM, Daemen MJAP, Vetter H, Bohm M. Estrogen modulates AT, receptor gene expression in vitro and in vivo. Circulation. 1998;97:2197-2201.
6. Takeda-Matsubara Y, Nakagami H, Iwai M, Cui TX, Shiuchi T, Akishita M, Nahmias C, Ito M, Horiuchi M. Estrogen activates phosphatases and antagonizes growth-promoting effects of angiotensin II. Hypertension, 2002;39:41-45.
7. de Gasparo M, Cart KJ, Inagami T, Wright JW, Unger T. International Union of Pharmacology, XXIII: the angiotensin II receptors. Pharmacol Rev. 2000;52:415-472.
8. Iwai N, Izumi M, Inagami T, Kinoshita M. Induction of renin in medial smooth muscle cells by balloon injury. Hypertension. 1997;29:1044-1050.
9. Rakugi H, Jacob HJ, Krieger JE, Ingelfinger JR, Pratt RE. Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation. 1993;97:293-290.
10. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest. 1994;93:339-346.
11. Akishita M, Shirakami G, Iwai M, Wu L, Aoki M, Zhang L, Toba K, Horiuchi M. Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice. J Hypertens. 2001;19:1083-1088.
12. 1 receptors in neointima of rat aorta. J Clin Invest. 1992;90:1707-1712.
13. 2 receptor expression and signaling. Physiol Genomics. 2000;2:13-20.
14. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: 10-year follow-up from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.
15. Walsh B, Schiff I, Rosner B, Greenberg L, Ravinkar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoprotein. N Engl J Med. 1991;325:1196-1204.
16. Wu L, Iwai M, Nakagami H, Li Z, Chen R, Suzuki J, Akishita M. Gasparo MD, Horiuchi M. Role of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation. 2001;104:2716-2721.
17. Bourassa PA, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 1996;93:10022-10227.
18. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension. 1998;31:152-161.
19. Zhang L, Fishman MC, Huang PL. Estrogen mediated the protective effects of pregnancy and chorionic gonadotropin in a mouse model of vascular injury. Arterioscler Thromb Vasc Biol. 1999;19:2059-2065.
20. Akishita M, Ouchi Y, Miyoshi H, Kozaki K, Inoue S, Ishikawa M, Eto M, Toba K, Orimo H. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis. 1997;130:1-10.
21. 1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. Am J Hypertens. 2000;13:504-511.
22. van Eickels M, Grohe C, Cleutjens JPM, Janssen BJ, Wellens HJJ, Doevendans PA. 17β-Estradiol attenuates the development of pressure-overload hypertrophy. Circulation. 2001;1014:1419-1423.
23. 2 receptors, regulates STAT activation by negative crosstalk. Circ Res. 1999;84:876-882.
24. Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol. 2001;208:F365-F388.
25. 2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell. Cardivasc Res. 2001;49:863-871.